达瑞动态
达瑞动态
DARUI NEWS
新冠专题 | 后疫情时代如何应对新冠病毒变异
加载中...
2023.03.24

参考文献:

[1] Yue C, Song W, Wang L, et al. Enhanced transmissibility of XBB. 1.5 is contributed by both strong ACE2 binding and antibody evasion[J]. bioRxiv, 2023. DOI: https://doi.org/10.1101/2023.01.03.522427

[2] https://www.medsci.cn/article/show_article.do?id=3fe2e5867491

[3] Li Dedong,Duan Minrun,Wang Xiao,Gao Pengyue,Zhao Xin,Xu Kun,Gao George F. Neutralization of BQ.1, BQ.1.1, and XBB with RBD-Dimer Vaccines.[J]. The New England journal of medicine, 2023. DOI: 10.1056/NEJMc2216233

[4] Liu ZZ, Zhou J,Wang XL, et al. A pan-sarbecovirus vaccine based on RBD of SARS-CoV-2 original strain elicits potent neutralizing antibodies against XBB in non-human primates[J]. PNAS, 2023. DOI: https://doi.org/10.1073/pnas.2221713120.

[5] http://m.ce.cn/gs/gd/202303/14/t20230314_38442145.shtml

[6] https://finance.eastmoney.com/a/202303172665371047.html


Copyright © 2023 广州市达瑞生物技术股份有限公司 粤ICP备2021150054号

Powered by vancheer